Pinned post
Ton van 't Noordende
Verified account This account is verified. Learn more@noordende
General Partner Ground State Ventures @GroundStateVC | A globally focussed $88 million venture capital fund, dedicated to investing in quantum technology
1.4K Following 2.3K Followers 5.1K Posts
Latest posts 5
Some big news from us here at @GroundStateVC today as we promote @KrisQuantum to partner ⚡️
Kris is exactly what our thesis calls for. You can't build a top performing portfolio in quantum without specialists who know the science cold
Kris is exactly what our thesis calls for. You can't build a top performing portfolio in quantum without specialists who know the science cold
The best part of investing early? Watching founders deliver on what you saw on day one.
@QuantWareHQ just closed a whopping $178 million Series B ⚡️ the largest private round ever raised by a dedicated quantum processor company.
@QuantWareHQ just closed a whopping $178 million Series B ⚡️ the largest private round ever raised by a dedicated quantum processor company.
Our portfolio company, @QuantWareHQ , has secured an impressive €20 million Series A 🚀
Their mission has always been to fast-track the development of quantum computing. Today, they are revealing how they plan to achieve this through QuantWare’s unique approach to modular, high-performance QPUs.
Absolutely remarkable:
👉 The team was first to deliver a commercially available quantum processor.
👉 Quantware now powers quantum computers for customers in 20 countries worldwide 🌎
👉 In parellel and under the radar, they have been developing VIO technology—a groundbreaking scaling innovation designed to create the world’s largest quantum processor.
Their mission has always been to fast-track the development of quantum computing. Today, they are revealing how they plan to achieve this through QuantWare’s unique approach to modular, high-performance QPUs.
Absolutely remarkable:
👉 The team was first to deliver a commercially available quantum processor.
👉 Quantware now powers quantum computers for customers in 20 countries worldwide 🌎
👉 In parellel and under the radar, they have been developing VIO technology—a groundbreaking scaling innovation designed to create the world’s largest quantum processor.
I'm excited to announce our investment in QT Sense (qtsense.com)⚡️
A stellar team —Romana, Deepak, Hoang— with a rare combination of deep quantum sensing and life sciences expertise, along with a great understanding of building and selling products.
This investment and funding from Interreg Europe, totalling €6M, enables QT Sense to accelerate growth and deliver the Quantum Nuova product line to crucial partners in the medical and scientific community.
It will support the development and distribution of Quantum Nuova to pharmaceutical researchers, clinicians, and discovery scientists who are focused on advancing treatments for cancer and other significant diseases.
By providing these key stakeholders with cutting-edge quantum sensing technology, the team aims to facilitate breakthroughs in understanding and treating complex diseases at the single-cell level
What a pleasure to work with this amazing team.
Onwards and upwards 🚀
@QDNLP
qtsense.com Home - QT Sense Free radical detection in live cells. Quantum Nuova offers 10x sensitivity and subcellular resolution for research and clinical use. A stellar team —Romana, Deepak, Hoang— with a rare combination of deep quantum sensing and life sciences expertise, along with a great understanding of building and selling products.
This investment and funding from Interreg Europe, totalling €6M, enables QT Sense to accelerate growth and deliver the Quantum Nuova product line to crucial partners in the medical and scientific community.
It will support the development and distribution of Quantum Nuova to pharmaceutical researchers, clinicians, and discovery scientists who are focused on advancing treatments for cancer and other significant diseases.
By providing these key stakeholders with cutting-edge quantum sensing technology, the team aims to facilitate breakthroughs in understanding and treating complex diseases at the single-cell level
What a pleasure to work with this amazing team.
Onwards and upwards 🚀
@QDNLP